种族和种族独立地预测了头部和部自移植手术后的不良结果
Tatiana Ferraro1,2, Abdulla K Ahmed1, Esther Lee1
1Division of Otolaryngology-Head and Neck Surgery, The George Washington University School of Medicine & Health Sciences, Washington, DC, U.S.A.
The Laryngoscope
|February 26, 2024
概括
种族和种族独立地预测了头部和部自移植手术后的并发症. 黑人患者面临更高的并发症和输血率,而西班牙裔患者的再手术和长时间住院时间增加.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 手术瘤学手术瘤学
- 健康差距 研究 研究 研究 研究
背景情况:
- 种族是导致头癌的已知因素.
- 关于种族/种族对头部和部自体移植手术的影响存在有限的研究,使用国家数据.
研究的目的:
- 评估种族和种族对头部和部自移植手术30天结果的影响.
- 根据种族/种族来确定手术并发症,重新手术和住院的差异.
主要方法:
- 使用了国家外科质量改进计划 (NSQIP) 数据库.
- 分析了2447名患者的数据,这些患者接受了头部和部自移植重建 (自由和踏脚).
- 采用二元物流回归来比较根据种族/民族身份的结果.
主要成果:
- 黑人患者的整体手术并发症和术后输血的几率显著更高.
- 西班牙裔患者的重新手术和延长住院时间 (>30天) 的可能性增加.
- 自由重建比脚式更常见 (80.71%),而不是脚式 (19.39%).
结论:
- 种族和族裔是头部和部自移植手术中术后并发症的独立预测因素.
- 确定了黑人和西班牙裔患者群体的特定不良结果差异.
更多相关视频
06:06Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
Published on: May 23, 2019
7.1K
13:16Computed Tomography and Optical Imaging of Osteogenesis-angiogenesis Coupling to Assess Integration of Cranial Bone Autografts and Allografts
Published on: December 22, 2015
11.4K
相关概念视频
Tissue Transplantation
366
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
366
Bone Marrow Sampling and Transplants
330
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
330
